Clinical Study
Influence of Age, Past Smoking, and Disease Severity on TLR2, Neutrophilic Inflammation, and MMP-9 Levels in COPD
Table 4
Multivariate linear regression outcomes to determine predictors of sputum neutrophil proportion.
| Variable | Coefficient | SE | | 95% confidence interval |
| Age, years | 0.068 | 0.232 | 0.771 | −0.400 to 0.537 | Sex (male/female) | 8.968 | 6.596 | 0.181 | −4.342 to 22.278 | Smoker (ex/never) | 2.988 | 6.994 | 0.671 | −11.123 to 17.103 | FEV1/FVC, % | −0.130 | 0.239 | 0.589 | −0.613 to 0.353 | Soluble TLR2 ng/mL | −0.048 | 0.137 | 0.729 | −0.324 to 0.228 | Log TLR2 gene expression | 16.244 | 4.793 | 0.002 | 6.570 to 25.917 | Log TLR4 gene expression | 12.405 | 9.104 | 0.180 | −5.968 to 30.778 | Log MMP-9 protein | 34.523 | 10.253 | 0.002 | 13.831 to 55.215 | Log NE | 2.122 | 5.566 | 0.705 | −9.110 to 13.354 | Log CXCL8 | −3.969 | 8.292 | 0.635 | −20.703 to 12.765 | Dose-inhaled corticosteroids, μg daily | −0.003 | 0.003 | 0.369 | −0.009 to 0.004 | Constant | −69.667 | 46.503 | 0.142 | −163.514 to 24.181 |
|
|